reSee.it - Related Video Feed

In a Phase one trial, a normal volunteer tests the safety of a potential vaccine. This process has been completed at a record speed. However, it will still take a few months to confirm its initial safety. The next step is a Phase two trial, involving hundreds or even thousands of people, which will take an additional 6 to 8 months to determine if the vaccine is effective. Overall, it will take around a year to a year and a half to know if the vaccine can be used. Another important aspect is ensuring that the vaccine does not worsen the infection. This can only be determined through extended studies involving individuals at risk. Previous cases have shown that vaccines that initially appeared safe actually made the situation worse. Therefore, caution is necessary before administering the vaccine.

The Pfizer vaccine has undergone standard clinical trials and received provisional authorization in New Zealand. It is not considered to be in a trial period anymore. With hundreds of millions of doses administered worldwide, there have been no alarming or unexpected findings. The evidence gathered from these vaccinations aligns with what was observed during the clinical trials and in other countries.

Vaccines are seen as magical but expectations should be tempered. Pfizer's vaccine is 95% effective, but efficacy drops over time. Boosters may be needed annually. Moderna is working on a combined flu and COVID vaccine. The future is uncertain, but we must adapt.

For the AstraZeneca vaccine, the range of efficacy in trials is based on various dosing intervals. The TGA will assess the best dosing interval for optimal efficacy in preventing severe disease. Importantly, early data suggests AstraZeneca may also effectively prevent disease transmission, which is crucial, especially for healthcare workers, in reducing outbreaks. While it's early and not peer-reviewed, there's a feeling that it significantly prevents transmission. We're still learning about the longevity of the vaccine's effects. The reported efficacy primarily focuses on preventing severe disease, where both vaccines show promise. The key is whether these vaccines prevent severe outcomes like death from COVID. Initial expectations were not necessarily to prevent infection, although there's emerging evidence suggesting potential reduction in transmission. Vaccine approval requires demonstrating a reduction in severe disease, which is the main focus at this stage.

The AstraZeneca vaccine is 100% effective against hospitalization and death, a crucial statistic that needs more attention. This information has only recently become available, and while the 70% effectiveness rate is also impressive, the focus should be on the strong protection it offers against severe outcomes.

In 2021, the goal is to manufacture a lot of vaccines to stop transmission and increase immunity. Vaccinated people do not carry or get sick from the virus, and the virus cannot infect them or use them to spread. Vaccines block the virus from getting and giving. Fully vaccinated individuals have a very low risk of getting COVID-19 and no longer need to wear masks. The vaccines are effective in breaking the chain of transmission and preventing surges. Vaccinated people are not at risk of hospitalization, ICU admission, or death from COVID-19.

The discussion centers on the current coverage of the AstraZeneca vaccine and the assessment of safety concerns that have been in the news. The speaker states a firm personal position regarding the vaccine, emphasizing continued confidence in its safety and specifically asserting that there is, at this point, no evidence that the AstraZeneca vaccine causes blood clots. This assertion is presented as a clear conclusion based on available information. Further support for this position comes from official health authorities. The TGA (Therapeutic Goods Administration) is described as closely monitoring the situation. The speaker notes that the TGA has issued a statement on the matter, which conveys the same core message: while they are aware of the situation and have maintained close contact with European authorities, there is no link identified between the AstraZeneca vaccine and the reported blood clot cases as of now. The implication is that ongoing vigilance will continue, but current data do not indicate a causal relationship between the vaccine and blood clots. In addition to Australian authorities, the international response is cited to reinforce the stance. The World Health Organization (WHO) is reported as having issued a similar assessment overnight, aligning with the local authorities’ conclusion that there is no established connection between the AstraZeneca vaccine and the blood clot concerns at this time. The speaker highlights this international corroboration to underscore a consensus across different health governance levels. Within Australia, there is mention of a collaborative and unanimous position among key health bodies. The speaker references full alignment between themselves, the TGA, and the ATAGI group (the Australian Technical Advisory Group on Immunisation), describing a united front regarding the current understanding of the vaccine’s safety profile in relation to blood clots. The language used signals a coordinated stance aimed at reassuring the public while continuing to monitor developments. Overall, the message conveyed is that, based on current information from national and international health authorities, there is no evidence linking the AstraZeneca vaccine to blood clots. The authorities are actively monitoring the situation, maintaining vigilance for any new data, and reiterating a consistent conclusion that supports the vaccine’s safety profile in this context. This summary captures the emphasis on confidence, ongoing surveillance, and concordant assessments from the TGA, ATAGI, and the WHO.

The Oxford AstraZeneca vaccine is safe and recommended by regulators. Over 11 million people have been vaccinated, showing it is safe and saving lives. It is important to get the jab when you have the chance to stay safe.

Now that we're coming out of the pandemic, the issue of variants will mainly be discussed by specialists. They will talk about the impact of these variants in conferences. Currently, the planned vaccination covers all variants. And does vaccination limit the emergence of new variants? Absolutely, by reducing the number of affected individuals. It decreases the portion of the population where the virus can multiply and mutate, thus leading to new variants. So, vaccination is absolutely essential to control the situation.

The World Health Organization supports the use of the Oxford AstraZeneca vaccine despite some countries pausing vaccinations due to blood clot concerns. There is no proven link between the vaccine and blood clots. AstraZeneca admitted in court that its COVID vaccine can cause rare blood clotting side effects, leading to lawsuits in the UK.

The COVID-19 vaccines have proven to be highly effective in the real world. Both the mRNA vaccine and another vaccine have shown efficacy rates of 94% to 95% for mild to moderate disease. In fact, the real world effectiveness of these vaccines is even more impressive than the results of the clinical trials. It is clear that these vaccines are highly effective in preventing COVID-19.

The omicron variant is a variant of concern, but there's no need to panic. It has many mutations that may allow it to enter our cells more easily, but it's unclear if it's more harmful or just more contagious. In South Africa, cases increased without a rise in deaths or hospitalizations, which is reassuring. Scientists are currently assessing the effectiveness of existing vaccines and treatments, including monoclonal antibodies, against this variant. Vaccine manufacturers like Novavax, Pfizer, and Moderna are proactively testing boosters specifically for omicron. Vaccination remains the best protection, and it's not too late to get vaccinated or receive a booster, along with the flu shot.

COVID-19 vaccines are described as safe and effective for various age groups, including children as young as five. Pfizer, Moderna, AstraZeneca, and Johnson & Johnson vaccines are highlighted. Studies and trials have confirmed the vaccines' safety and efficacy, with some showing high effectiveness in preventing symptomatic infections and severe disease. The FDA and European Medicines Agency have assessed and approved these vaccines. A booster shot different from the original vaccination is likely safe and effective. The vaccines are considered a key tool, along with mask-wearing and social distancing, to combat the spread of COVID-19 and return to normalcy.

Being vaccinated keeps you safe and reduces transmission. Unvaccinated people pose the highest risk of spreading the virus and facing severe illness. Vaccination offers over a 98% chance of avoiding COVID. The third dose provides protection against severe illness and infection. AstraZeneca's vaccine has been approved but faced bans in some countries. Data shows more COVID deaths in vaccinated individuals in the US. The global vaccination trial proves that vaccines are safe and effective.

According to the CDC, vaccinated individuals don't carry or get sick from the virus, both in clinical trials and real-world data. However, reports from international colleagues, like Israel, indicate a higher risk of severe disease among those vaccinated early. This evidence raises concerns that the strong protection against severe infection, hospitalization, and death could decrease in the future, particularly for those at higher risk or vaccinated earlier during the rollout phases.

Vaccines are seen as magical, but expectations may need to be lowered. Pfizer's vaccine is 95% effective, but efficacy rates can fluctuate. Protection may only last a year, requiring annual shots. Moderna is working on a combined flu and COVID vaccine. The future is uncertain, but there is hope for improvement in the next 5 years.

Safe and effective vaccines have been developed and millions of doses are being delivered. The vaccines have been rigorously studied and proven to be safe and effective. Researchers have confirmed the safety and efficacy of various vaccines, including the Oxford AstraZeneca and Pfizer COVID-19 vaccines. Vaccination has been deemed safe and effective for children, with Pfizer's vaccine being 100% effective for kids aged 5 to 11. The European Medicines Agency has thoroughly assessed the vaccines and concluded they are safe and effective against COVID-19. The vaccines have undergone extensive testing and have been found to be extremely safe and effective. Overall, vaccines are considered safe, effective, and free.

There is confidence in the AstraZeneca vaccine, and there is no evidence that it causes blood clots. The TGA is closely monitoring the situation and released a statement saying that they do not see any link between the vaccine and blood clots. The TGA, ATAGI, and the speaker are in unanimous agreement that there is no link between AstraZeneca and blood clots. The World Health Organization also addressed the issue.

The AstraZeneca vaccine is safe and effective against Covid-19. It is recommended to get vaccinated with any available vaccine as they are all safe and effective. They not only protect against severe illness but also reduce the risk of spreading the virus to others. Looking back at the past year, we have made significant progress with three vaccines that are safe and effective. It is advised for everyone to get vaccinated against Covid-19 to effectively control the pandemic.

Multiple studies have shown the safety and effectiveness of COVID-19 vaccines. In Israel, a study found that the vaccines were 97% effective against symptomatic infection and 86% effective against asymptomatic infection in healthcare workers. In the United States, vaccines were 90% effective against any infection and 94% effective against hospitalizations from COVID-19 in healthcare workers across multiple states. The Pfizer vaccine has also been found to be effective against common variants in the US, such as B117 and B1351. Similar effectiveness has been observed with the Moderna and Johnson & Johnson vaccines. Even if someone does get infected after vaccination, the infection is likely to have a lower viral load, be shorter in duration, and have a lower risk of transmission to others.

Vaccinated individuals are protected against COVID-19 and its variants, as the vaccines are highly effective. They do not carry the virus, get sick, or transmit it to others. Vaccination allows society to return to normal by reducing transmission. Getting both vaccine shots is crucial. Vaccinated people are safe from hospitalization, ICU stays, and death, and they no longer need to wear masks. However, they cannot prevent transmission. Israel's experience suggests a waning of immunity, indicating the need for booster shots. The plan is for every adult to receive a booster shot. Overall, vaccines have been a highly successful investment.

AstraZeneca pulled their vaccine due to decreased demand and lack of effectiveness against new strains. Vaccines were effective in preventing severe disease, but issues need further study. Vaccine reactions should be reported and studied, but long COVID from the virus affects more people. Prioritizing high-risk groups for vaccination is crucial. Transparency and addressing concerns are key to combating misinformation. Lessons must be learned for future pandemics.

Regulators, including the MHRA, European regulator, and World Health Organization, have found that all three COVID-19 vaccines used in the UK are safe and effective, saving thousands of lives. The vaccine rollout is going well, and the safety system is working. The AstraZeneca vaccine is not recommended for those under 30, but alternatives will be offered to ensure safety. The vaccine has not been tested on children as their risk of significant harm from COVID-19 is low. All data and side effects are being transparently shared. Face masks are recommended in hospitals, care homes, and some other environments. Vaccination not only protects individuals but also reduces transmission and brings us closer to normalcy. The UK regulator is independent and not influenced by external pressure. Leaving the EU allowed the UK to make authorization decisions faster while maintaining safety checks.

Vaccinated individuals are protected against COVID-19 and its variants, as the vaccines are highly effective. They do not carry the virus, get sick, or transmit it to others. Vaccination allows society to return to normal. Fully vaccinated people no longer need to wear masks or practice physical distancing, and they are unlikely to be hospitalized or die from the virus. However, vaccines only slightly reduce transmission, and there is a need for new vaccination strategies. Reports from Israel suggest a waning of immunity, indicating the importance of booster shots. The plan is for every adult to receive a booster shot.

Vaccination not only protects individuals but also reduces virus transmission, helping society return to normal. Current data indicates that vaccinated individuals do not carry the virus or get sick. Getting vaccinated and boosted can save lives and prevent serious illness. The goal is to stop the virus from spreading by ensuring vaccinated individuals act as dead ends for transmission. Vaccines are effective enough that when a vaccinated person is exposed, the virus cannot infect them or spread further. However, there was uncertainty about the vaccines' ability to stop transmission at the time of emergency use authorization. The data on this was limited, and it was acknowledged that the speed of development impacted the understanding of transmission prevention.